Australia markets closed

Valneva SE (INRLF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
14.08-0.01 (-0.07%)
At close: 02:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close14.09
Open14.10
BidN/A x N/A
AskN/A x N/A
Day's range13.93 - 14.10
52-week range4.45 - 18.55
Volume1,100
Avg. volume6,698
Market cap1.41B
Beta (5Y monthly)0.87
PE ratio (TTM)N/A
EPS (TTM)-1.33
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Valneva Announces Termination of Liquidity Contract with Oddo BHF and Natixis and Publishes End of Contract Statement
    GlobeNewswire

    Valneva Announces Termination of Liquidity Contract with Oddo BHF and Natixis and Publishes End of Contract Statement

    Saint-Herblain (France), June 11, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announces today that it has terminated the liquidity agreement relating to its ordinary shares concluded with Oddo BHF and Natixis on June 25, 2018, as the liquidity of the Company’s securities has improved. The termination is effective as of today. The f

  • Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate
    GlobeNewswire

    Valneva Completes Recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate

    Saint Herblain (France), June 10, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced that it has completed recruitment for the clinical lot-to-lot consistency Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. VLA1553 is the only chikungunya vaccine candidate in Phase 3 clinical trials at this time. 4

  • Déclaration d’actions et de droits de vote de la société Valneva SE – Mai 2021
    GlobeNewswire

    Déclaration d’actions et de droits de vote de la société Valneva SE – Mai 2021

    VALNEVA Déclaration d’actions et de droits de vote – Mai 2021 Dénomination sociale : VALNEVAAdresse du siège social : 6 rue Alain Bombard, 44800 Saint-HerblainMarché réglementé Euronext Paris - Compartiment B Date de la déclaration : Déclaration du 7 juin 2021 Nombre d’actions composant le capital de Valneva : 99 908 938 Nombre total de droits de vote incluant les droits de vote suspendus (droits de vote bruts ou théoriques) : 126 995 096 Origine de la variation : Augmentation de capital sans ma